Adapting to Progress: Evolving nAMD Trials Amid Therapeutic Expansion cover art

Adapting to Progress: Evolving nAMD Trials Amid Therapeutic Expansion

Adapting to Progress: Evolving nAMD Trials Amid Therapeutic Expansion

Listen for free

View show details

About this listen

 Drs. Dilsher Dhoot and Arshad M. Khanani explain the key aspects of the recently released FDA guidelines for clinical trial design in neovascular age-related macular degeneration and how these changes will influence the interpretation of clinical trial data and the subsequent integration of these therapies into clinical practice. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.